Umoove
Jerusalem · Founded 2010
About Umoove
Umoove created a face and eye-tracking solution that is compatible with any smartphone or tablet with a front facing camera. Umoove's technology does not require any additional hardware of any kind. Umoove develops in-house medical applications and, at the same time, is powering eye tracking research in top universities across the world. Eye tracking is used as a method for diagnose and therapy of many neurological disorders such as ADHD, concussions, traumatic brain injury, Alzheimer's, autism, strokes and more. Umoove's first product, uHealth, was released in early 2015 and can be found on the AppStore. Outside of the mHealth space, Umoove shares it's SDK with qualifying third party developers in various markets such as gaming, automotive, analytics, advertising and wearable's.
Company Facts
- Founded: 2010
- Legal name: Umoove LTD.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $2.5M
- Last round: Convertible Note (Jan 2016)
- Website: umoove.me
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/umoove-8346401 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.